share_log

Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why

Benzinga Real-time News ·  Apr 8, 2022 12:20
  • Kaleido Biosciences Inc (NASDAQ:KLDO) has delivered formal notice to voluntarily delist its common stock from NASDAQ as the Company will stop all operations.
  • The Company expects to file a Form 25 with the Securities and Exchange Commission by April 18 to effect the voluntary delisting effective by April 28.
  • The Board of Directors voted to immediately wind down and cease all of the Company's ongoing operations. 
  • Related: Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target.
  • In connection with the cessation of activities, the employment of all of the Company's remaining employees was terminated effective immediately. 
  • As previously announced, the Company had initiated a strategic process, but it did not result in the identification of any viable transactions, given its limited remaining resources.
  • The Company cannot continue operations and believes that the best alternative is an orderly wind-down process. 
  • Price Action: KLDO shares are down 74.9% at $0.37 during the market session on the last check Friday.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment